Your browser doesn't support javascript.
loading
Stromal progenitor cell modulation by thalidomide in the treatment of oral chronic graft-versus-host disease.
Davies, Lindsay C; Board-Davies, Emma; Shamlou, Berfin; Boberg, Erik; Garming-Legert, Karin; Le Blanc, Katarina.
Afiliación
  • Davies LC; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden. Electronic address: Lindsay.Davies@ki.se.
  • Board-Davies E; School of Dentistry, Cardiff University, Cardiff, United Kingdom.
  • Shamlou B; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Boberg E; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Divisions of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Garming-Legert K; Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Le Blanc K; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Divisions of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden.
Cytotherapy ; 20(5): 755-758, 2018 05.
Article en En | MEDLINE | ID: mdl-29580863

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2018 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2018 Tipo del documento: Article Pais de publicación: Reino Unido